PPS to expand API manufacturing capabilities in Asia and North America
Announces investments worth $55 million
Author
Marksans Pharma gets EIR from US FDA for its Goa facility
EIR is issued to a company detailing inspectional findings
Lupin receives FDA approval for generic Corgard Tablets
Nadolol Tablets are indicated for management of patients with angina pectoris and for the treatment of hypertension
Intas Pharma brings down cancer treatment cost by 60%
Bevacizumab is used in treating multiple-cancers like colorectal cancer, ovarian cancer, cervical cancer, lung cancer and…
SPARC’s Baclofen GRS fails to meet primary end point in placebo controlled studies
The study consisted of a total of 293 subjects in the intent to treat population
IIT Roorkee scientists identify drug to fight Chikungunya virus
The molecular details revealed in the study can be further utilised to design piperazine derivative drugs that are more potent and…
Granules India gets EIR from USFDA for OmniChem facility
OmniChem facility is operated by 50:50 joint venture of Granules India and Ajinimoto OmniChem
Novartis divests anti-infectives brands to Samara Capital
The portfolio of brands acquired focus on anti-infectives largely catering to the women's health and gynaecology segment
Fosun Pharma acquires 74 per cent stake in Gland Pharma for $1.09 bn
Following the completion of the acquisition, Gland Pharma has become an indirect non-wholly owned subsidiary of Fosun Pharma and…
MoH&FW to introduce new TB drug in controlled manner
As a pilot, 400 courses of Delamanid will be rolled out in five to six states as part of the conditional access programme under…